⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PCRX News
Pacira BioSciences, Inc. Common Stock
After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead
globenewswire.com
CNXU
ESTA
INMD
PCRX
TELA
Pacira BioSciences Reports Real-World Study Showing EXPAREL® Use Was Associated with Reduced Opioid Use and Healthcare Costs in Patients Undergoing Total Shoulder Arthroplasty
globenewswire.com
PCRX
Pacira BioSciences Sets the Record Straight Regarding DOMA’s Misleading Statements About Pacira’s Intellectual Property Strategy
globenewswire.com
PCRX
A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching
globenewswire.com
PCRX
SSYS
SNN
ELUT
A LETTER TO PACIRA BIOSCIENCES SHAREHOLDERS FROM DOMA PERPETUAL CAPITAL MANAGEMENT LLC
prnewswire.com
PCRX
DOMA Perpetual Director Nominees Send Letter to Shareholders of Pacira Biosciences
prnewswire.com
PCRX
Pacira BioSciences Files Investor Presentation Highlighting Successful Execution of its Long-Term Strategy to Drive Value for All Stockholders
globenewswire.com
PCRX
DOMA Perpetual Issues & Mails Letter to Shareholders of Pacira BioSciences - Along with its Definitive Proxy Statement & WHITE Proxy Card - Urging Shareholders to Vote "FOR" DOMA's Three Highly Qualified, Independent Board Candidates
prnewswire.com
PCRX
Pacira BioSciences to Participate in Fireside Chats at Three Upcoming Healthcare Conferences
globenewswire.com
PCRX
Pacira BioSciences Sends Letter to Stockholders Reiterating Superior Qualifications of its Board Nominees
globenewswire.com
PCRX